Cytotoxic activity of hantap (Sterculia oblongata Mast) leaves extract against breast cancer cells line (MCF7/HER2): the effect on the expression of HER2 mRNA and the apoptosis
Abstract
Hantap leaves (Sterculia oblongata Mast) has been used traditionally to treat breast cancer in Palu, Central Sulawesi. However, its use is just based on empirical evidences rather than scientific evidences. The study aimed to investigate the cytotoxic activity of hantap leaves extracts against breast cancer cells line. The effect of this extract on the HER2 expression and the apoptosis was also evaluated. The hantap (S. oblongata Mast) leaves extracts were prepared by consecutive maceration method using n-hexane, methanol and water, respectively. The cytotoxic activity against MCF7/HER2 breast cancer cells line was evaluated using the MTT assay with doxorubicin as a positive control. The HER2 mRNA expression was examined using RT-PCR and the apoptosis after 24 h incubation was examined using a fluorescence microscope after AO-PI (acridine orange-propidium iodide) staining. Among three extracts tested, the methanolic extract exhibited the most cytotoxic against MCF7/HER2 cells with an IC50 of 91.25 μg/mL. Therefore, the methanolic extract was subjected to further study. The methanolic extract at concentration of 1/2IC50; 1IC50 and 2IC50 μM induced 6.8; 26.3 and 25.3% apoptosis of the MFC7/HER2 cell lines, respectively. The methanolic extract at concentration of 1/2IC50; 1IC50 and 2IC50 μM inhibited HER2 mRNA expression to be 0.6; 0.25 and 0.33 compared to control cells. In conclusion, the methanolic extract of hantap leaves (S. oblongata Mast) has cytotoxic activity against MCF7/HER2 breast cancer cell lines by induce cells apoptosis and inhibit HER2 mRNA expression. Further study, will be conducted to isolate active constituents as anticancer.
References
American Cancer Society. Cancer facts and figures. American Cancer Society, Atlanta; 2017. Available from : https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html
World Health Organization. Breast cancer. WHO; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer
International Agency for Reseach on Cancer. Indonesia. World Health Organization, 2020. Available from : https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf
Kementiran Kesehatan RI. Info jenis kanker ini rentan menyerang manusia 2020. Kementerian Kesehatan Republik Indonesia. Jakarta, 2020. Available from: https://www.kemkes.go.id.
Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular
pathogenesis. Gene Dis 2018; 5:77-106.
https://doi.org/10.1016/j.gendis.2018.05.001
Wong DJL, Hurvitz SA. Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugates. Ann Transl Med 2014; 2(12): 122.
http://doi.org/10.3978/j.issn.2305-5839.2014.08.13
Mendes D, Alves C, Afonso N, Cardoso F, Passos-Coelho JL, Costa L, et al. The benefit of HER2 targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer: a systematic review. Breast Cancer Res 2014; 17(140). 1-14.
https://doi.org/10.1186/s13058-015-0648-2
Yokoyama Y, Matsumoto A, Hieda M, Shinchi Y, Ogihara E, Hamada M, et al. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity. Breast Cancer Res 2014; 16(R66): 1-12.
Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol 2010; 4(3):174-91.
https://doi.org/10.1016/j.molonc.2010.04.011
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144(5):646-74.
https://doi.org/10.1016/j.cell.2011.02.013
Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17, 395–417 (2020).
https://doi.org/10.1038/s41571-020-0341-y
Sun SY, Hail NJ, Lotan R. Apoptosis as a novel target for cancer chemoprevention. JNCI 2004; 96(5): 662-72.
https://doi.org/10.1093/jnci/djh123
Murningsih T, Praptiwi, Liana, Fathoni A. TLC profiling and antioxidant activity of phenolic compound from Sterculia oblongata bark extract. Nusantara Bioscience 2019; 11(1):44-8.
https://doi.org/10.13057/nusbiosci/n110108
Ezeonu CS, Ejikeme CM. Qualitative and quantitative determination of phytochemical contents of indigenous Nigerian Softwoods. New J Sci 2016; 5601327.
https://doi.org/10.1155/2016/5601327
Sajjadi SE, Ghanadian M, Haghighi M, Mouhebat L. Cytotoxic effect of Cousiniaver bascifolia bunge against OVCAR-3 and HT-29 cancer cells. J Her Med Pharmacol 2015; 4(1):15-9.
Murtiningsih T, Pratiwi, Liana, Fathoni A. TLC profiling and antioxidant activity of phenolic compound from Sterculia oblongata bark extract. Nusa Biosci 2019; 11(1): 44-8.
https://doi.org/10.13057/nusbiosci/n110108
El Sherei MM, Ragheb AY, Kassem M, Marzouk M, Mosarrafa S, Saleh N, Phytochemistry, biological activities and economical uses of the genus Sterculia and the related genera: A review. Asian Pacific J Trop Dis 2016; 6(6): 492-501.
https://doi.org/10.1016/S2222-1808(16)61075-7
Neha K, Haider MR, Pathak A, Yar MS. Medicinal prospects of antioxidants: A review. Eur J Med Chem 2019;178:687-704.
https://doi.org/10.1016/j.ejmech.2019.06.010.
Athreya K, Xavier MF. Antioxidants in the treatment of cancer. Nutr Cancer 2017; 69(8):1099-1104.
https://doi.org/10.1080/01635581.2017.1362445.
Tai W, Mahato R, Cheng K. The role of HER2 in cancer therapy and targeted drug delivery. J Control Release 2010;146(3):264-75.
https://doi.org/10.1016/j.jconrel.2010.04.009.
Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, et al. Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res 2008;68(22):9280-90.
https://doi.org/10.1158/0008-5472.CAN-08-1776.
Galati G, Teng S, Moridani MY, Chan TS, O’Brien, PJ. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol Drug Interact 2000; 17(1-4):311-49.
https://doi.org/10.1515/dmdi.2000.17.1-4.311.
Elmore, S. (2007). Apoptosis: A Review of Programmed Cell Death. Toxicol Pathol. 35: 495-516.
Paus R, Rosenbach T, Haas N, Czarnetski BM. Patterns of cell death: the significance of apoptosis in dermatology. Exp Dermatol 1993; 2:3-11.
https://doi.org/10.1111/j.1600-0625.1993.tb00192.x.
Martin S.J., Green D.R. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 1995; 8:137–53.
